The Risks of Unverified Sources: Why a Doctor's Prescription and Reputable Pharmacy are Key Obtaining Sermorelin from unregulated sources is dangerous due to risks of unverified quality, purity, dosage, and sterility, especially for injectables. Rely on a qualified healthcare provider and a licensed, reputable compounding pharmacy for safe access
10.3389/fonc.2023.1193762 [DOI] [PMC free article] [PubMed] [Google Scholar] Shirabe K., Mano Y., Muto J., Matono R., Motomura T., Toshima T., et al
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
The final canister and parents' diaries were collected at this time
